Research Archive

Access our complete library of scientific publications, white papers, and research studies.

Addiction, Neuropsychiatric & Behavioral Research

CHRNA5 D398N mutation in addiction: Pathogenic insights and therapeutic discovery

Drug addiction is a significant public health issue, with genetic components playing a role in predisposing a person to susceptibility.

Addiction, Neuropsychiatric & Behavioral Research

Identification of novel amides and alkaloids as putative inhibitors of dopamine transporter for schizophrenia using computer-aided virtual screening

Schizophreniaisacomplexpsychiatricdisordermarkedbydelusions,memory impairments, hallucinations, disorganized behavior, and severe cognitive deficits.

Addiction, Neuropsychiatric & Behavioral Research

CHRNA5 D398N mutation in addiction: Pathogenic insights and therapeutic discovery

Drug addiction is a significant public health issue, with genetic components playing a role in predisposing a person to susceptibility.

Biostatistics, Meta-Analysis & Evidence Synthesis

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023

A systematic analysis for the Global Burden of Disease Study 2023

Biostatistics, Meta-Analysis & Evidence Synthesis

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023:

A systematic analysis for the Global Burden of Disease Study 2023

Biostatistics, Meta-Analysis & Evidence Synthesis

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023

A demographic analysis for the Global Burden of Disease Study 2023

Cancer Biology & Precision Oncology

PD-L1 targeting in triple negative breast cancer

In silico and in vitro validation of wasp venom peptide MP-1

Cancer Biology & Precision Oncology

Fucoidan From Brown Algae as a Functional Food Ingredient

A Promising Anticancer Agent

Cancer Biology & Precision Oncology

Navigating PROTACs in Cancer Therapy

Advancements, Challenges, and Future Horizons

Cancer Biology & Precision Oncology

Recent Insights Into Breast Cancer

Molecular Pathways, Epigenetic Regulation, and Emerging Targeted Therapies

Cancer Biology & Precision Oncology

Advancing brain tumor therapy

unveiling the potential of PROTACs for targeted protein degradation

Cancer Biology & Precision Oncology

Liquid biopsy in breast cancer

clinical implications of ctDNA and CTCs in diagnosis, treatment and monitoring

Cancer Biology & Precision Oncology

Thapsigargin and its prodrug derivatives

Exploring novel approaches for targeted cancer therapy through calcium signaling disruption

Cancer Biology & Precision Oncology

Anticancer efficacy of Spiruchostatin A

current insights into histone deacetylase inhibition and oncologic applications

Computational Drug Discovery & Molecular Modeling

Computational identification and evaluation of novel PD-L1 inhibitors for cancer immunotherapy

Antibody-based therapies targeting the PD-1/PD-L1 pathway have shown promise in anticancer immunotherapy; however, challenges such as high cost, immunogenicity, and limited penetration highlight the need for small-molecule inhibitors.

Biostatistics, Meta-Analysis & Evidence Synthesis

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally.

Biostatistics, Meta-Analysis & Evidence Synthesis

Global burden of lower respiratory infections and aetiologies, 1990–2023

a systematic analysis for the Global Burden of Disease Study 2023

Biostatistics, Meta-Analysis & Evidence Synthesis

Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030

a systematic analysis for the Global Burden of Disease Study 2023

Computational Drug Discovery & Molecular Modeling

In vitro investigation of Datura innoxia phytocompounds against Mycobacterium tuberculosis H37Ra strain in association with in silico studies

Tuberculosis (TB) is a recurrent and progressive bacterial disease caused by Mycobacterium tuberculosis (Mtb), posing a significant challenge globally due to its drug resistance.

Computational Drug Discovery & Molecular Modeling

Computer-aided screening of marine fungal metabolites as potential inhibitors of new Delhi metallo-beta-lactamase-1

New Delhi metallo-beta-lactamase-1 (NDM-1) is a protein produced by bacteria carrying the blaNDM-1 gene, leading to antibiotic resistance, a major global health issue. NDM-1 hydrolyzes nearly all beta-lactam antibiotics, including last-resort carbapenems

Computational Drug Discovery & Molecular Modeling

Bacterial Metabolite‑Derived NDM‑1 Inhibitors

A Computational Strategy to Overcome β‑Lactam Resistance

Computational Drug Discovery & Molecular Modeling

Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer

Human Papilloma Virus type 16 (HPV-16) is highly oncogenic with the E6 and E7 oncogenes playing crucial roles in the pathogenesis of HPV-related cervical car cinogenesis.

Computational Drug Discovery & Molecular Modeling

Lipoxygenase inhibitory potential of secondary metabolites isolated from Pistacia integerrima

A comprehensive in vitro analysis integrating molecular docking, ADMET and DFT studies

Computational Drug Discovery & Molecular Modeling

Aldose reductase inhibitory evaluation and in silico studies of bioactive secondary metabolites isolated from Fernandoa.

Diabetes and its associated secondary complications represent significant global health challenges. This study aimed to address these issues by investigating Fernandoa adenophylla, a plant utilized in various alternative medicine systems for its antidiabetic properties.

Computational Drug Discovery & Molecular Modeling

Identification of Datura innoxia as a potential source of antimycobacterial components

Datura innoxia is a medicinal plant from the Solanaceae family, having medicinal properties and some toxic effects.

Computational Drug Discovery & Molecular Modeling

Aloe vera Phytochemicals as Potential Antibacterial Agents Against Multidrug-Resistant Pseudomonas aeruginosa

Multidrug-resistant (MDR) Pseudomonas aeruginosa poses a global challenge due to its high virulence and resistance mechanisms, which lead to persistent infections.

Computational Drug Discovery & Molecular Modeling

Identifying novel inhibitors against drug resistant mutant CYP-51 Candida albicans

A computational study to combat fungal infections

Computational Drug Discovery & Molecular Modeling

Unveiling a novel ellagic acid derivative as a potent lipoxygenase (LOX) inhibitor

Integration of computational modeling and experimental validation

Computational Drug Discovery & Molecular Modeling

Anti-inflammatory potential of Grewialin from Grewia optiva

Insights from molecular docking, ADMET, DFT, and in-vitro studies

Computational Drug Discovery & Molecular Modeling

Genetic analysis of HPV‑16 L1 gene mutations and computational screening of therapeutic inhibitors for cervical cancer treatment

Cervical cancer, the fourth most common carcinoma in women worldwide, is predominantly caused by persistent infection with high risk human papillomavirus (HR-HPV).

Computational Drug Discovery & Molecular Modeling

Identification and evaluation of pyrimidine based CDK6 inhibitors against glioblastoma using integrated computational approaches

Cyclin-dependent kinases (CDKs) are crucial for controlling the cell cycle, and many malignancies are linked to CDK dysfunction.

Computational Drug Discovery & Molecular Modeling

A combined in silico and MD simulation approach to discover novel LpxC inhibitors targeting multiple drug resistant Pseudomonas aeruginosa

Pseudomonas aeruginosa (P. aeruginosa), a member of the ESKAPE family, is the major cause of infections leading to increased morbidity and mortality due to multidrug resistance (MDR).

Human Genetics & Genomic Medicine

Gene Editing for Cystic Fibrosis: Advances and Prospects of CRISPR‐Cas9 Therapy

Cystic fibrosis (CF), also known as mucoviscidosis, is a relatively common monogenic, autosomal recessive disorder.

Human Genetics & Genomic Medicine

Impact of the CYP27B1 p.R389H mutation on protein stability and function

Implications for multiple sclerosis pathogenesis

Human Genetics & Genomic Medicine

Novel ATOH7 mutation and structural characterization in families with optic nerve hypoplasia

To detect and segregate causative mutations in congenital families with optic nerve hypoplasia (ONH).

Human Genetics & Genomic Medicine

Novel insight into CFTR gene’s single nucleotide variants classification via in-silico analysis of a conserved site

Mutations in the CFTR gene play a pivotal role in the onset/severity of cystic fibrosis (CF). While our understanding of CFTR mutation classes is fragmented, this study focused on missense single nucleotide variants (SNVs) in the ABC transporter-like conserved site of the CFTR protein, employing various bioinformatics tools to identify deleterious amino acid substitutions (A.A.S).

Human Genetics & Genomic Medicine

In Silico Analysis of CYP1B1 Gene Mutations in Pakistani Families Reveals Structural and Functional Characteristics

Mutations in the CYP1B1 gene have been associated with primary congenital glaucoma (PCG), a developmental visual disorder. CYP1B1 mutations have been linked to increased lipid peroxidation and abnormalities in trabecular meshwork.

Human Genetics & Genomic Medicine

Molecular Characterization of Oculocutaneous Albinism in Consanguineous Pakistani Families

Unraveling Disease‑Causing Pathogenic Variants in OCA2 and TYR Genes for Precision Diagnosis

Human Genetics & Genomic Medicine

Unraveling the genetic connections for mitochondrial DNA control region and breast cancer susceptibility

Breast cancer, a complex global health concern, has predominantly been studied for nuclear DNA variations.

Immunoinformatics, Vaccines & Infectious Diseases

Computational identification of membrane proteins for vaccine design against drug-resistant Moraxella catarrhalis

Moraxella catarrhalis is a Gram-negative diplococcus bacterium and a common respiratory pathogen, implicated in 15–20 % of otitis media (OM) cases in children and chronic obstructive pulmonary disease (COPD) in adults.

Immunoinformatics, Vaccines & Infectious Diseases

Computational design of an mRNA vaccine targeting antifungal resistant Lomentospora prolificans

Lomentospora prolificans is an emerging opportunistic pathogen that predominantly affects immunocompromised individuals, as well as healthy individuals, often leading to disseminated disease with high mortality rates.

Immunoinformatics, Vaccines & Infectious Diseases

In-silico design and evaluation of a novel mRNA vaccine against human bocavirus 1

Human Bocavirus 1 (HBoV1) majorly affects infants and children, resulting severe lower respiratory tract in fections.

Immunoinformatics, Vaccines & Infectious Diseases

In-silico core proteome analysis for chimeric vaccine development against tick-borne tularemia

Tularemia is an extremely contagious zoonotic illness resulting from infection with the intracellular bacterium Francisella tularensis.

Immunoinformatics, Vaccines & Infectious Diseases

Core genome analysis reveals novel drug and vaccine targets in multidrug-resistant Citrobacter koseri

Citrobacter koseri is a Gram-negative, multidrug-resistant bacterium linked to severe infections in immunocompromised individuals and neonates.

Immunoinformatics, Vaccines & Infectious Diseases

Bioinformatics-guided decoding of the Ancylostoma duodenale genome for the identification of potential vaccine targets

Ancylostoma duodenale, commonly known as the Old World hookworm, is a parasitic nematode (roundworm) belonging to the family Ancylostomatidae.

Nanotechnology & Experimental Biomedical Research

Citronellol silver nanoconjugates as a therapeutic strategy for glioblastoma through computational and experimental evaluation

Glioblastoma is the most prevalent type of brain tumor, and because of drug resistance, treatment for gliomas has been less successful.

Nanotechnology & Experimental Biomedical Research

Novel Linalool-Silver nanoparticles: Synthesis, characterization, and dual approach evaluation via computational docking and antibacterial assays

In recent years, scientists have developed new medical delivery techniques based on nanotechnology and have been actively creating nanoparticles combined with various extracts from natural plant products.

Nanotechnology & Experimental Biomedical Research

Linalool-based silver nanoconjugates as potential therapeutics for glioblastoma

In silico and in vitro insights